antibiotics

antibiotics are powerful medicines used to fight infections caused by bacteria. They work by either killing the bacteria or inhibiting their growth, allowing the body's immune system to eliminate the infection. Their discovery revolutionized modern medicine, turning previously fatal diseases into treatable conditions. However, their effectiveness is threatened by the rise of antibiotic resistance.

History

The concept of using substances to treat infection has ancient roots, with early civilizations using molds and plants. The modern era began with the work of Louis Pasteur and Robert Koch, who established the germ theory of disease. A pivotal breakthrough occurred in 1928 when Alexander Fleming observed the antibacterial properties of a mold, Penicillium notatum, leading to the discovery of penicillin. Its large-scale production was achieved during World War II through the efforts of Howard Florey and Ernst Chain. The subsequent Golden Age of Antibiotics saw the discovery of many new classes, such as streptomycin by Selman Waksman, which earned him the Nobel Prize in Physiology or Medicine. Organizations like the World Health Organization have since emphasized their critical role in global health.

Medical uses

These drugs are prescribed for a wide range of bacterial conditions, from common ailments like streptococcal pharyngitis and urinary tract infection to life-threatening situations such as sepsis, meningitis, and pneumonia. They are also essential in preventing infections after major surgeries, like coronary artery bypass grafting or joint replacement, and in managing conditions in immunocompromised patients, such as those undergoing chemotherapy. Their use is strictly for bacterial infections; they are ineffective against illnesses caused by influenza, the common cold, or other viruses.

Side effects

While generally safe, these medications can cause adverse reactions. Common issues include gastrointestinal disturbances, such as nausea and diarrhea, and allergic reactions ranging from mild rash to severe anaphylaxis. Some, like aminoglycosides, can cause ototoxicity, affecting the cochlea, and nephrotoxicity. Broad-spectrum types can disrupt the normal gut flora, leading to secondary infections like Clostridioides difficile infection. Regulatory agencies like the U.S. Food and Drug Administration and the European Medicines Agency monitor these risks closely.

Classes

These agents are categorized into groups based on their chemical structure and activity. Major classes include penicillins, such as amoxicillin, discovered from the original Penicillium mold. Cephalosporins, like ceftriaxone, are structurally related and often used in hospitals. Other important groups are macrolides (e.g., azithromycin), tetracyclines (e.g., doxycycline), fluoroquinolones (e.g., ciprofloxacin), and aminoglycosides (e.g., gentamicin). Each class has a distinct spectrum of activity against different pathogens like Staphylococcus aureus or Escherichia coli.

Mechanisms of action

These compounds target specific, essential processes in bacterial cells. Beta-lactams, including penicillins and cephalosporins, inhibit the synthesis of the peptidoglycan cell wall. Macrolides and tetracyclines bind to the bacterial ribosome, blocking protein synthesis. Fluoroquinolones interfere with enzymes like DNA gyrase, crucial for DNA replication. Sulfonamides are antimetabolites that inhibit folic acid synthesis. These selective targets, often absent or different in human cells, are the basis for their therapeutic utility.

Resistance

This phenomenon occurs when bacteria evolve mechanisms to survive exposure. Key methods include producing enzymes like beta-lactamase that destroy the drug, altering the drug's target site (as seen in methicillin-resistant Staphylococcus aureus), or using efflux pumps to remove the agent. Misuse and overuse in human medicine and agriculture, such as in livestock feed, accelerate this process. Global initiatives led by the World Health Organization, the Centers for Disease Control and Prevention, and the European Centre for Disease Prevention and Control promote antimicrobial stewardship to preserve efficacy. The spread of resistant genes, like those for New Delhi metallo-beta-lactamase 1, represents a major global health threat. Category:Antibiotics